Lauren Dembeck, PhD

Researchers sought to determine whether loss of MRD bone marrow negativity after ASCT could predict relapse in patients with multiple myeloma.

Researchers sought to determine whether palliative care was different for patients with hematological malignancies than for those with other malignancies.

Researchers reviewed epitranscriptomics and the prospects of precision medicines that target AML-associated genes.

Researchers sought to determine whether acalabrutinib would be safe and effective in patients with treatment-naïve CLL who declined or were in ineligible for chemotherapy.

Researchers present data on use of palliative care in the last 30 days of life and the impact on costs among those who did and did not receive palliative care.

A comparison of incidence rates and disparities in cardiovascular risk factors among survivors of childhood cancers compared to siblings and the general public was presented at 2021 ASCO Annual Meeting.

Researchers present results of a clinical trial that evaluated the impact of an LHW intervention on care use and behaviors among patients with advanced cancer and at the end of life during the 2021 ASCO Annual Meeting.

Researchers sought to determine whether adding bortezomib to bendamustine-rituximab induction therapy would improve survival in patients with mantle cell lymphoma.

Results of a secondary analysis on oncology-patient communications regarding FS and PP concerns were presented at the 2021 ASCO Annual Meeting.

A symptom-adapted physical activity intervention helped older adults with AML to maintain their physical function while undergoing induction chemotherapy.